Nicolas Charloteaux - 28 Sep 2020
In response to the devastating human and economic cost of the COVID-19 crisis, our members are working in collaboration with academic institutions, European and international organisations as well as across the life sciences sector to find vaccines that can stop the coronavirus pandemic in its tracks.
These vaccines will be assessed by the European Medicines Agency (EMA) and other regulators around the world. They will only be approved based on rigorous and objective scientific review of safety and efficacy data based on large-scale, high quality, randomised and observer-blinded clinical trials. The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients of a COVID-19 vaccine.
Read our full statement on the safety of Covid-19 vaccines here.